Inhibition of the CaM-Kinases augments cell death in response to oxygen radicals and oxygen radical inducing cancer therapies in MCF-7 human breast cancer cells

Cancer Biology and Therapy

Volumn 5, Issue 8, 2006, Pages 1022-1030

  Rodriguez Mora, Oswaldo G ^a   Lahair, Michelle M ^a   Evans, Mark J ^a   Kovacs, Charles J ^a   Allison, Ron R ^a   Sibata, Claudio H ^a   White, Kawana S ^a   McCubrey, James A ^a   Franklin, Richard A ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Breast cancer; CaM KII; Chemotherapy; PDT; Radiotherapy

Indexed keywords

CALMODULIN; CALMODULIN DEPENDENT KINASE; CALMODULIN DEPENDENT KINASE II; CALMODULIN DEPENDENT KINASE IV; DNA FRAGMENT; DOXORUBICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; OXYGEN RADICAL; PROTEIN KINASE B; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER THERAPY; CELL DEATH; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; IONIZING RADIATION; PHOTODYNAMIC THERAPY;

EID: 33751170050     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.5.8.2910     Document Type: Article

References (55)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ. Cancer statistics, 2005. CA Cancer J Clin 2005; 55:10-30.
2. Dixon JM, Gregory K, Johnston S, Rodger A. Breast cancer (nonmetastatic). Clin Evid 2004; 2300-33.
3. Stebbing J, Glassman R. Breast cancer (metastatic). Clin Evid 2004; 2266-99.
4. Allison R, Mang T, Hewson G, Snider W, Dougherty D. Photodynamic therapy for chest wall progression from breast carcinoma is an underutilized treatment modality. Cancer 2001; 91:1-8.
5. Cuenca RE, Allison RR, Sibata C, Downie GH. Breast cancer with chest wall progression: Treatment with photodynamic therapy. Ann Surg Oncol 2004; 11:322-7.
6. Bast Jr RC, Hortobagyi GN. Individualized care for patients with cancer - A work in progress. N Engl J Med 2004; 351:2865-7.
7. Hook SS, Means AR. Ca(2+)/CaM-dependent kinases: From activation to function. Annu Rev Pharmacol Toxicol 2001; 41:471-505.
8. Matsushita M, Nairn AC. Characterization of the mechanism of regulation of Ca2+/calmodulin-dependent protein kinase I by calmodulin and by Ca2+/calmodulin-dependent protein kinase kinase. J Biol Chem 1998; 273:21473-81.
9. Minami H, Inoue S, Hidaka H. The effect of KN-62, Ca2+/calmodulin dependent protein kinase II inhibitor on cell cycle. Biochem Biophys Res Commun 1994; 199:241-8.
10. Howe CJ, LaHair MM, Maxwell JA, Lee JT, Robinson PJ, Rodriguez-Mora O, McCubrey JA, Franklin RA. Participation of the calcium/calmodulin-dependent kinases in hydrogen peroxide-induced Ikappa B phosphorylation in human T lymphocytes. J Biol Chem 2002; 277:30469-76.
11. Howe CJ, Lahair MM, McCubrey JA, Franklin RA. Redox regulation of the calcium/calmodulin-dependent protein kinases. J Biol Chem 2004; 279:44573-81.
12. Mates JM, Sanchez-Jimenez FM. Role of reactive oxygen species in apoptosis: Implications for cancer therapy. Int J Biochem Cell Biol 2000; 32:157-70.
13. Curtin JF, Donovan M, Cotter TG. Regulation and measurement of oxidative stress in apoptosis. J Immunol Methods 2002; 265:49-72.
14. Huang P, Feng L, Oldham EA, Keating MJ, Plunkett W. Superoxide dismutase as a target for the selective killing of cancer cells. Nature 2000; 407:390-5.
15. Cleveland JL, Kastan MB. Cancer: A radical approach to treatment. Nature 2000; 407:309-11.
16. Halliwell B. A super way to kill cancer cells? Nat Med 2000; 6:1105-6.
17. Kobayashi D, Tokino T, Watanabe N. Contribution of caspase-3 differs by p53 status in apoptosis induced by X-irradiation. Jpn J Cancer Res 2001; 92:475-81.
18. Dvorakova K, Payne CM, Tome ME, Briehl MM, McClure T, Dorr RT. Induction of oxidative stress and apoptosis in myeloma cells by the aziridine-containing agent imexon. Biochem Pharmacol 2000; 60:749-58.
19. Friesen C, Fulda S, Debatin KM. Induction of CD95 ligand and apoptosis by doxorubicin is modulated by the redox state in chemosensitive- and drug-resistant tumor cells. Cell Death Differ 1999; 6:471-80.
20. McLaughlin KA, Osborne BA, Goldsby RA. The role of oxygen in thymocyte apoptosis. Eur J Immunol 1996; 26:1170-4.
21. Matroule JY, Carthy CM, Granville DJ, Jolois O, Hunt DW, Piette J. Mechanism of colon cancer cell apoptosis mediated by pyropheophorbide-a methylester photosensitization. Oncogene 2001; 20:4070-84.
22. Herrmann M, Lorenz HM, Voll R, Grunke M, Woith W, Kalden JR. A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res 1994; 22:5506-7.
23. 2/M transition and independently of increased signaling by the JNK/c-Jun pathway. Int J Oncol 2000; 16:413-22.
24. Rodriguez-Mora OG, LaHair MM, McCubrey JA, Franklin RA. CaM-KI and CaM-KK participate in the control of cell cycle progression in MCF-7 human breast cancer cells. Cancer Res 2005; 65:5408-5416.
25. Guyton KZ, Liu Y, Gorospe M, Xu Q, Holbrook NJ. Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury. J Biol Chem 1996; 271:4138-42.
26. Sonoda Y, Watanabe S, Matsumoto Y, Aizu-Yokota E, Kasahara T. FAK is the upstream signal protein of the phosphatidylinositol 3-kinase-Akt survival pathway in hydrogen peroxide-induced apoptosis of a human glioblastoma cell line. J Biol Chem 1999; 274:10566-70.
27. Toledano MB, Leonard WJ. Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proc Natl Acad Sci USA 1991; 88:4328-32.
28. Storz P, Toker A. NF-kappaB signaling-an alternate pathway for oxidative stress responses. Cell Cycle 2003; 2:9-10.
29. Atherfold PA, Norris MS, Robinson PJ, Gelfand EW, Franklin RA. Calcium-induced ERK activation in human T lymphocytes. Mol Immunol 1999; 36:543-9.
30. Franklin RA, Atherfold PA, McCubrey JA. Calcium-induced ERK activation in human T lymphocytes occurs via p56(Lck) and CaM-kinase. Mol Immunol 2000; 37:675-83.
31. Illario M, Cavallo AL, Bayer KU, Di Matola T, Fenzi G, Rossi G, Vitale M. Calcium/calmodulin-dependent protein kinase II binds to Raf-1 and modulates integrin-stimulated ERK activation. J Biol Chem 2003; 278:45101-8.
32. Schmitt JM, Wayman GA, Nozaki N, Soderling TR. Calcium activation of ERK mediated by calmodulin kinase I. J Biol Chem 2004; 279:24064-72.
33. Yano S, Tokumitsu H, Soderling TR. Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway. Nature 1998; 396:584-7.
34. Hughes K, Edin S, Antonsson A, Grundstrom T. Calmodulin-dependent kinase II mediates T cell receptor/CD3- and phorbol ester-induced activation of IkappaB kinase. J Biol Chem 2001; 276:36008-13.
35. Cai H, Davis ME, Drummond GR, Harrison DG. Induction of endothelial NO synthase by hydrogen peroxide via a Ca(2+)/calmodulin-dependent protein kinase II/janus kinase 2-dependent pathway. Arterioscler Thromb Vasc Biol 2001; 21:1571-6.
36. Tang K, Liu C, Kuluz J, Hu B. Alterations of CaMKII after hypoxia-ischemia during brain development. J Neurochem 2004; 91:429-37.
37. Nguyen A, Chen P, Cai H. Role of CaMKII in hydrogen peroxide activation of ERK1/2, p38 MAPK, HSP27 and actin reorganization in endothelial cells. FEBS Lett 2004; 572:307-13.
38. Jiang H, Zhang L, Koubi D, Kuo J, Groc L, Rodriguez AI, Hunter TJ, Tang S, Lazarovici P, Gautam SC, Levine RA. Roles of Ras-Erk in apoptosis of PC12 cells induced by trophic factor withdrawal or oxidative stress. J Mol Neurosci 2005; 25:133-140.
39. Nair VD, Yuen T, Olanow CW, Sealfon SC. Early single cell bifurcation of pro- and antiapoptotic states during oxidative stress. J Biol Chem 2004; 279:27494-501.
40. Nair VD, Olanow CW, Sealfon SC. Activation of phosphoinositide 3-kinase by D2 receptor prevents apoptosis in dopaminergic cell lines. Biochem J 2003; 373:25-32.
41. Hu Y, Bally M, Dragowska WH, Mayer L. Inhibition of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase enhances chemotherapeutic effects on H460 human nonsmall cell lung cancer cells through activation of apoptosis. Mol Cancer Ther 2003; 2:641-9.
42. Weinstein-Oppenheimer CR, Henriquez-Roldan CF, Davis JM, Navolanic PM, Saleh OA, Steelman LS, Franklin RA, Robinson PJ, McMahon M, McCubrey JA. Role of the Raf signal transduction cascade in the in vitro resistance to the anticancer drug doxorubicin. Clin Cancer Res 2001; 7:2898-907.
43. Wang T, Hu YC, Dong S, Fan M, Tamae D, Ozeki M, Gao Q, Gius D, Li JJ. Coactivation of ERK, NF-kappa B and GADD45beta in response to ionizing radiation. J Biol Chem 2005; 280:12593-601.
44. Akimoto T, Nonaka T, Ishikawa H, Sakurai H, Saitoh JI, Takahashi T, Mitsuhashi N. Genistein, a tyrosine kinase inhibitor, enhanced radiosensitivity in human esophageal cancer cell lines in vitro: Possible involvement of inhibition of survival signal transduction pathways. Int J Radiat Oncol Biol Phys 2001; 50:195-201.
45. Assefa Z, Vantieghem A, Declercq W, Vandenabeele P, Vandenheede JR, Merlevede W, de Witte P, Agostinis P. The activation of the c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signaling pathways protects HeLa cells from apoptosis following photodynamic therapy with hypericin. J Biol Chem 1999; 274:8788-96.
46. Tong Z, Singh G, Rainbow AJ. Sustained activation of the extracellular signal-regulated kinase pathway protects cells from photofrin-mediated photodynamic therapy. Cancer Res 2002; 62:5528-35.
47. Wagner BA, Evig CB, Reszka KJ, Buettner GR, Burns CP. Doxorubicin increases intracellular hydrogen peroxide in PC3 prostate cancer cells. Arch Biochem Biophys 2005; 440:181-90.
48. Wei SJ, Botero A, Hirota K, Bradbury CM, Markovina S, Laszlo A, Spitz DR, Goswami PC, Yodoi J, Gius D. Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation. Cancer Res 2000; 60:6688-95.
49. Chekulayeva LV, Shevchuk IN, Chekulayev VA, Ilmarinen K. Hydrogen peroxide, superoxide, and hydroxyl radicals are involved in the phototoxic action of hematoporphyrin derivative against tumor cells. J Environ Pathol Toxicol Oncol 2006; 25:51-70.
50. Mooney LM, Al-Sakkaf KA, Brown BL, Dobson PR. Apoptotic mechanisms in T47D and MCF-7 human breast cancer cells. Br J Cancer 2002; 87:909-17.
51. Zapata JM, Krajewska M, Krajewski S, Huang RP, Takayama S, Wang HG, Adamson E, Reed JC. Expression of multiple apoptosis-regulatory genes in human breast cancer cell lines and primary tumors. Breast Cancer Res Treat 1998; 47:129-40.
52. Tang D, Kidd VJ. Cleavage of DFF-45/ICAD by multiple caspases is essential for its function during apoptosis. J Biol Chem 1998; 273:28549-52.
53. Saunders DE, Lawrence WD, Christensen C, Wappler NL, Ruan H, Deppe G. Paclitaxel-induced apoptosis in MCF-7 breast-cancer cells. Int J Cancer 1997; 70:214-20.
54. Hishikawa K, Oemar BS, Tanner FC, Nakaki T, Luscher TF, Fujii T. Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7. J Biol Chem 1999; 274:37461-6.
55. Tudor G, Aguilera A, Halverson DO, Laing ND, Sausville EA. Susceptibility to drug-induced apoptosis correlates with differential modulation of Bad, Bcl-2 and Bcl-xL protein levels. Cell Death Differ 2000; 7:574-86.3